Does MYCOPHENOLATE MOFETIL Cause Thrombotic microangiopathy? 820 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 820 reports of Thrombotic microangiopathy have been filed in association with MYCOPHENOLATE MOFETIL (Mycophenolate mofetil). This represents 1.1% of all adverse event reports for MYCOPHENOLATE MOFETIL.
820
Reports of Thrombotic microangiopathy with MYCOPHENOLATE MOFETIL
1.1%
of all MYCOPHENOLATE MOFETIL reports
165
Deaths
300
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From MYCOPHENOLATE MOFETIL?
Of the 820 reports, 165 (20.1%) resulted in death, 300 (36.6%) required hospitalization, and 68 (8.3%) were considered life-threatening.
Is Thrombotic microangiopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MYCOPHENOLATE MOFETIL. However, 820 reports have been filed with the FAERS database.
What Other Side Effects Does MYCOPHENOLATE MOFETIL Cause?
Off label use (13,474)
Drug ineffective (7,729)
Product use in unapproved indication (5,910)
Diarrhoea (3,628)
Cytomegalovirus infection (3,278)
Pneumonia (3,017)
Pyrexia (2,927)
Condition aggravated (2,883)
Covid-19 (2,706)
Transplant rejection (2,500)
What Other Drugs Cause Thrombotic microangiopathy?
TACROLIMUS (1,982)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)
MELPHALAN (332)
Which MYCOPHENOLATE MOFETIL Alternatives Have Lower Thrombotic microangiopathy Risk?
MYCOPHENOLATE MOFETIL vs MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL vs MYCOPHENOLIC ACID
MYCOPHENOLATE MOFETIL vs MYFORTIC
MYCOPHENOLATE MOFETIL vs MYRBETRIQ
MYCOPHENOLATE MOFETIL vs NABILONE